BEUDAMED
    FDA Adverse Event Injury Summary report: N

    HYALGAN

    MDR report key: 235072 · Received March 26, 1999

    Report

    Report Number
    MW1016933
    Event Type
    Injury
    Date Received
    March 26, 1999
    Date of Event
    January 11, 1999
    Report Date
    March 26, 1999
    Manufacturer
    FIDIA PHARMACEUTICAL CORP.
    Product Code
    LZX
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    NY, US
    Reporter Occupation
    OTHER

    Narratives

    Description of Event or Problem · 1

    AN ORTHOLOGICS REP REPORTED THAT A CONSUMER HAD AN "INJECTION SITE REACTION" WHICH REQUIRED SUBSEQUENT HOSPITALIZATION AND TREATMENT WITH IV ANTIBIOTICS. CORRECTIVE TREATMENT: IV ANTIBIOTICS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 HYALGAN INTRA-ARTICULAR INJECTION LZX FIDIA PHARMACEUTICAL CORP. NI UNK

    Patients

    Seq Age Sex Outcome Treatment
    1 64 YR Hospitalization| R